PI3Kδ Is a Therapeutic Target in Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

PI3Kδ Is a Therapeutic Target in Hepatocellular Carcinoma

Author:

Ko Eunkyong¹^ORCID,Seo Hyun-Wook¹,Jung Eun Sun²,Ju Soomi¹³,Kim Baek-hui⁴,Cho Hyeki⁵,Kim Yoon Jun⁵,Park Young Min⁶,Kim Jong-Seo¹³,Jung Guhung¹^ORCID

Affiliation:

1. Department of Biological Sciences, College of Natural Sciences; Seoul National University; Seoul South Korea

2. Department of Pathology; Seoul St. Mary’s Hospital, the Catholic University of Korea; Seoul South Korea

3. Center for RNA Research; Institute of Basic Science (IBS); Seoul South Korea

4. Department of Pathology; Korea University Guro Hospital, Korea University College of Medicine; Seoul South Korea

5. Department of Internal Medicine and Liver Research Institute; Seoul National University College of Medicine; Seoul South Korea

6. Hepatology Center and Laboratory of Hepatocarcinogenesis; Bundang Jesaeng General Hospital; Kyungkido South Korea

Funder

the Korea Healthcare Technology Research and Development Project of the Ministry of Health and Welfare of the Republic of Korea

Institute for Basic Science of Korea

Publisher

Wiley

Subject

Hepatology

Link

Reference37 articles.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献